Document is current
Any future updates will be listed below
-
Authors
Seehaus, Cristian Maximiliano
Remaggi, Guillermina
Filho, Jayr Schmidt
Ochoa, Paola
Bigni, Ricardo
de Magalhães, Roberto José Pessoa
Dalfeor, Ruddy
Aggarwal, Bhumika
Soares, Claudia
Bitetti, Jacopo
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 5 September 2025
Accepted: 23 October 2025
First Online: 26 November 2025
Declarations
:
: Guillermina Remaggi declares receiving honoraria as a speaker from Janssen, Sanofi and Pfizer; advisory board for Janssen, Sanofi, Pfizer and GSK. Roberto José Pessoa de Magalhães declares receiving honoraria as a speaker and on advisory boards from Bristol Myers Squibb, GSK, Janssen, Pfizer and Sanofi. Cristian Maximiliano Seehaus, Jayr Schmidt Filho, Ricardo Bigni and Ruddy Dalfeor have no conflicts of interest to disclose. Paola Ochoa declares receiving honoraria as a speaker from Bristol Myers Squibb, GSK, Johnson and Johnson and Sanofi; advisory board for Bristol Myers Squibb, GSK, Johnson and Johnson, Pfizer and Sanofi; travel support from Johnson and Johnson and Sanofi. Bhumika Aggarwal and Jacopo Bitetti are employed by GSK and hold financial equities in GSK. Claudia Soares was an employee of GSK and held financial equities in GSK at the time of manuscript initiation.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
